Griffin Stephen D. — SEC Form 4 filings
SEC reporting owner CIK 1831125. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-12 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 12,200 shares, $149,881 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: purchase of 12,200 shares @ $12.29 ($149,881) in Anika Therapeutics, Inc., filed 2026-04-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | President and CEO, Director | 7 | 1 leg · 12,200 sh · $149,881 | — | 16 |
| VSE CORP (VSEC) | Senior Vice President and CFO | 2 | — | — | 11 |
Form 4 filings — Griffin Stephen D.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Anika Therapeutics, Inc. (ANIK) | Option exercise (M): 12,840 · Tax withholding (F): 3,769 @ $14.41 · Option exercise (M): 12,840 (derivative) @ $0 | EDGAR |
| 2026-04-30 | 4 | Anika Therapeutics, Inc. (ANIK) | Purchase (P): 12,200 @ $12.29 | EDGAR |
| 2026-03-17 | 4 | Anika Therapeutics, Inc. (ANIK) | Option exercise (M): 12,824 · Grant/award (A): 6,412 @ $0 · Tax withholding (F): 5,944 @ $14.20 · Option exercise (M): 12,824 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Anika Therapeutics, Inc. (ANIK) | Grant/award (A): 310,207 (derivative) @ $0 · Grant/award (A): 130,402 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Anika Therapeutics, Inc. (ANIK) | Option exercise (M): 12,840 @ $0 · Tax withholding (F): 3,769 @ $11.59 · Option exercise (M): 12,840 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Anika Therapeutics, Inc. (ANIK) | Grant/award (A): 38,473 (derivative) @ $0 · Grant/award (A): 18,672 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Anika Therapeutics, Inc. (ANIK) | Grant/award (A): 38,520 (derivative) @ $0 · Grant/award (A): 96,525 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | VSE CORP (VSEC) | Grant/award (A): 2,567 @ $0 · Option exercise (M): 1,287 @ $0 · Tax withholding (F): 1,160 @ $79.02 | EDGAR |
| 2024-03-12 | 4 | VSE CORP (VSEC) | Option exercise (M): 1,832 · Grant/award (A): 5,132 @ $0 · Option exercise (M): 1,324 · Grant/award (A): 1,821 @ $0 · Tax withholding (F): 3,031 @ $75.12 · Grant/award (A): 3,549 (derivative) @ $0 · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1831125 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →